Document Detail

MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
MedLine Citation:
PMID:  16371574     Owner:  NLM     Status:  MEDLINE    
PURPOSE: To prospectively compare oral contrast-enhanced T2-weighted half-Fourier rapid acquisition with relaxation enhancement (RARE) magnetic resonance (MR) imaging with T1-weighted gadolinium-enhanced fast low-angle shot (FLASH) MR and standard examinations in the evaluation of Crohn disease.
MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained. Fifty-nine patients with Crohn disease underwent MR imaging after oral administration of a superparamagnetic contrast agent; RARE plain and fat-suppressed sequences and FLASH sequences were performed before and after intravenous injection of gadolinium chelate. References were endoscopic, small-bowel barium, computed tomographic, ultrasonographic, and clinical-biochemical scoring of disease activity. Two radiologists analyzed MR images for presence and extent of Crohn disease lesions, presence of strictures or other complications, and degree of local inflammation. MR findings were correlated with endoscopic, radiologic, and clinical data (kappa statistic and Spearman rank correlation test).
RESULTS: T2-weighted MR was 95% accurate, 98% sensitive, and 78% specific for detection of ileal lesions. Agreement between T1- and T2-weighted images ranged from 0.77 for ileal lesions to 1.00 for colic lesions. T2-weighted MR enabled detection of 26 of 29 severe strictures, 17 of 24 enteroenteric fistulas, and all adhesions and abscesses; T1-weighted MR enabled detection of 20 of 29 severe strictures, 16 of 24 enteroenteric fistulas, and all adhesions and abscesses. Complications leading to surgery were found in 12 (20%) patients; these were assessed correctly with either T1- or T2-weighted images. T2-weighted signal intensities of the wall and mesentery correlated with biologic activity (P < .001, r of 0.774 and 0.712, respectively). Interobserver agreement was 0.642-1.00 for T2-weighted and 0.711-1.00 for T1-weighted images.
CONCLUSION: T2-weighted MR can depict Crohn disease lesions and help assess mural and transmural inflammation with the same accuracy as gadolinium-enhanced T1-weighted MR. Combination of gadolinium-enhanced T1- and T2-weighted sequences is useful in the assessment of Crohn disease.
Francesca Maccioni; Antonio Bruni; Angelo Viscido; Maria Chiara Colaiacomo; Andrea Cocco; Chiara Montesani; Renzo Caprilli; Mario Marini
Related Documents :
23498984 - Diffusion-weighted mr imaging of focal liver lesions in the left and right lobes: is th...
8115614 - Granulocytic sarcoma in childhood leukemia: imaging features.
16642344 - Hibernoma--correlation of histopathology and magnetic-resonance-imaging features in 10 ...
25013504 - A new phantom and empirical formula for apparent diffusion coefficient measurement by a...
24964564 - Radiological presentation of neurosarcoidosis.
25425724 - Apparent diffusion coefficient for lymph node characterization after chemoradiation the...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2005-12-21
Journal Detail:
Title:  Radiology     Volume:  238     ISSN:  0033-8419     ISO Abbreviation:  Radiology     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-01-26     Completed Date:  2006-02-23     Revised Date:  2013-09-27    
Medline Journal Info:
Nlm Unique ID:  0401260     Medline TA:  Radiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  517-30     Citation Subset:  AIM; IM    
Copyright Information:
(c) RSNA, 2005
Department of Radiological Sciences, Clinical Sciences, Gastroenterology Unit, and Surgical Sciences, University of Rome La Sapienza, Via Regina Elena 324, 00161 Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Contrast Media*
Crohn Disease / diagnosis*
Gadolinium DTPA / diagnostic use*
Iron / diagnostic use*
Magnetic Resonance Imaging* / methods
Magnetite Nanoparticles
Middle Aged
Oxides / diagnostic use*
Prospective Studies
Siloxanes / diagnostic use*
Reg. No./Substance:
0/Contrast Media; 0/Magnetite Nanoparticles; 0/Oxides; 0/Siloxanes; 0/ferumoxsil; 1317-61-9/Ferumoxytol; 7439-89-6/Iron; 80529-93-7/Gadolinium DTPA
Erratum In:
Radiology. 2013 Aug;268(2):614

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pulse stimulation with odors or IBMX/forskolin potentiates responses in isolated olfactory neurons.
Next Document:  Optimal peak systolic velocity threshold at duplex us for determining the need for carotid endartere...